Pharma News

Not Disclosed Neurodegeneration by Eli Lilly and Co for Neurodegenerative Diseases: Likelihood of Approval

Not Disclosed Neurodegeneration is under clinical development by Eli Lilly and Co and currently in Phase I for Neurodegenerative Diseases.

Source link
#Disclosed #Neurodegeneration #Eli #Lilly #Neurodegenerative #Diseases #Likelihood #Approval

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *